Free Trial
NASDAQ:BIOA

BioAge Labs (BIOA) Stock Price, News & Analysis

$4.33 +0.01 (+0.23%)
As of 08/8/2025 04:00 PM Eastern

About BioAge Labs Stock (NASDAQ:BIOA)

Key Stats

Today's Range
$4.27
$4.35
50-Day Range
N/A
52-Week Range
$2.88
$26.62
Volume
44,756 shs
Average Volume
106,404 shs
Market Capitalization
$155.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioAge Labs and its competitors with MarketBeat's FREE daily newsletter.

BIOA Stock News Headlines

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions of Americans at risk of blackouts and could lead to a crisis "many times worse than 2008" if not fixed.
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

BioAge Labs' stock was trading at $4.20 on January 1st, 2025. Since then, BIOA stock has increased by 3.1% and is now trading at $4.33.

BioAge Labs, Inc. (NASDAQ:BIOA) announced its quarterly earnings results on Wednesday, August, 6th. The company reported ($0.60) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by $0.04.

BioAge Labs (BIOA) raised $198 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 11,000,000 shares at a price of $18.00 per share.

Top institutional investors of BioAge Labs include Geode Capital Management LLC (1.26%), Intech Investment Management LLC (0.04%), Public Employees Retirement System of Ohio (0.04%) and Police & Firemen s Retirement System of New Jersey (0.02%).

Shares of BIOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BIOA
CIK
1709941
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$71.11 million
Net Margins
N/A
Pretax Margin
-2,045.74%
Return on Equity
-25.39%
Return on Assets
-23.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.21
Quick Ratio
13.68

Sales & Book Value

Annual Sales
$1.45 million
Price / Sales
106.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.22 per share
Price / Book
0.53

Miscellaneous

Outstanding Shares
35,850,000
Free Float
28,386,000
Market Cap
$155.23 million
Optionable
N/A
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BIOA) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners